671 related articles for article (PubMed ID: 17719657)
1. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
2. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
Zhou K; He H; Wu Y; Duan M
J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
[TBL] [Abstract][Full Text] [Related]
5. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
6. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene.
Wu Y; Zhang G; Li Y; Jin Y; Dale R; Sun LQ; Wang M
Biochem Biophys Res Commun; 2008 Jan; 365(2):369-74. PubMed ID: 17996729
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ
Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
Zhang T; Zhao PS; Zhang W; Liang M; Gao YW; Yang ST; Wang TC; Qin C; Wang CY; Xia XZ
Vaccine; 2011 Feb; 29(8):1558-64. PubMed ID: 21215341
[TBL] [Abstract][Full Text] [Related]
10. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
[TBL] [Abstract][Full Text] [Related]
11. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
[TBL] [Abstract][Full Text] [Related]
12. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
[TBL] [Abstract][Full Text] [Related]
13. siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus.
Behera P; Nagarajan S; Murugkar HV; Kalaiyarasu S; Prakash A; Gothalwal R; Dubey SC; Kulkarni DD; Tosh C
J Biosci; 2015 Jun; 40(2):233-40. PubMed ID: 25963253
[TBL] [Abstract][Full Text] [Related]
14. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
[TBL] [Abstract][Full Text] [Related]
15. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses.
Li IW; Chan KH; To KW; Wong SS; Ho PL; Lau SK; Woo PC; Tsoi HW; Chan JF; Cheng VC; Zheng BJ; Chen H; Yuen KY
J Clin Virol; 2009 Dec; 46(4):325-30. PubMed ID: 19801200
[TBL] [Abstract][Full Text] [Related]
16. A live bivalent influenza vaccine based on a H9N2 virus strain.
Wu R; Guan Y; Yang Z; Chen J; Wang H; Chen Q; Sui Z; Fang F; Chen Z
Vaccine; 2010 Jan; 28(3):673-80. PubMed ID: 19892041
[TBL] [Abstract][Full Text] [Related]
17. Rapid subtyping of H9N2 influenza virus by a triple reverse transcription polymerase chain reaction.
Chen HT; Zhang J; Ma LN; Ma YP; Ding YZ; Wang M; Liu XT; Zhang YG; Liu YS
J Virol Methods; 2009 Jun; 158(1-2):58-62. PubMed ID: 19428570
[TBL] [Abstract][Full Text] [Related]
18. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
Ernst WA; Kim HJ; Tumpey TM; Jansen AD; Tai W; Cramer DV; Adler-Moore JP; Fujii G
Vaccine; 2006 Jun; 24(24):5158-68. PubMed ID: 16713037
[TBL] [Abstract][Full Text] [Related]
19. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Zhirnov OP; Klenk HD
Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.
Sui HY; Zhao GY; Huang JD; Jin DY; Yuen KY; Zheng BJ
PLoS One; 2009 May; 4(5):e5671. PubMed ID: 19479060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
